Journal profile · CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
ISSN 0102-695X · eISSN 1981-528X · Springer International Publishing · BRAZIL · 6 issues per year · Founded 2015
Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.67; fully open access; APC about USD 2,990; median 126 days to acceptance (99 articles, last 24 months); community-reported acceptance: easy; 111 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy is published by Springer International Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Phytochemistry Medicinal Plant Applications, Essential Oils and Antimicrobial Activity and Natural product bioactivities and synthesis, together about 38.5% of its articles. Its main subfields are Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
The Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy is a periodical dedicated to the publication of original scientific work, reviews and communications in the field of Pharmacognosy, the study of plants, animals and microorganisms as a possible source of bioactive natural products. Pharmacognosy is defined, by the Brazilian Society of Pharmacognosy, as the study of the physical, chemical, biochemical, and biological properties of drugs, drug substances or potential drugs of natural origin. The following areas of interest are covered by the journal:Ethnobotany and ethnopharmacologyPharmacobotanyPlant biotechnologyMetabolomicsPhytochemistryOrganic synthesis and analytical studiesBiological and pharmacological activitiesPharmacokinetic studiesDelivery system for natural productsPhytopharmaceutical technologyMicrobial and marine natural product chemistry and biotechnology
From the journal's Aims & Scope
Research area (LetPub): CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
Editor-in-chief João Carlos Palazzo dePublisher website
Editorial board by country: none in mainland China; most named Brazil 26, Italy 3, Germany 1, Spain 1, Portugal 1 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Phytochemistry Medicinal Plant ApplicationsAgricultural and Biological Sciences16.4%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences13.5%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology8.5%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences7.8%
- Ethnobotanical and Medicinal Plants StudiesAgricultural and Biological Sciences5.5%
- Phytochemicals and Antioxidant ActivitiesMedicine4.1%
- Bee Products Chemical AnalysisAgricultural and Biological Sciences3.4%
- Insect Pest Control StrategiesAgricultural and Biological Sciences3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.67LetPub ·
- Impact factor (publisher) 2025
- 1.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.7Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 0.54LetPub ·
- h-index
- 37LetPub ·
- h-index
- 89OpenAlex ·
- i10-index
- 1,630OpenAlex ·
- 2-year mean citedness
- 1.51OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 10.56%LetPub ·
Volume
- Articles per year
- 109LetPub ·
- Downloads per year (publisher) 2025
- 190,500Publisher website ·
Articles by year OpenAlex count · 2,862 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 85 | 31 | 17 |
| 2025 | 111 | 11 | 128 |
| 2024 | 107 | 17 | 312 |
| 2023 | 151 | 29 | 813 |
| 2022 | 124 | 28 | 905 |
| 2021 | 98 | 20 | 980 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
126 daysMedian, submission to acceptance · P25–P75 97 days – 182 days
- Acceptance to online
- median 27 days (101 articles)
- Submission to online
- median 166 days
- Sample
- 99 articles with submission and acceptance dates (212 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 28 daysPublisher website ·
- Peer review
- Double anonymous peer review, Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,990 / EUR 2,390 / GBP 2,090 | — | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,000 words
- Reference style
- Author–date
- Graphical abstract
- Required
Article types accepted7, with length limits
- original paperThe Brazilian Journal of Pharmacognosy accepts for publication original scientific work, reviews and communication articles written only in English. • Original …main text ≤ 3,000 words
- perspectiveThe Brazilian Journal of Pharmacognosy accepts for publication original scientific work, reviews and communication articles written only in English. • Original …Length not stated
- research articleThe Brazilian Journal of Pharmacognosy accepts for publication original scientific work, reviews and communication articles written only in English. • Original …Length not stated
- reviewThe Brazilian Journal of Pharmacognosy accepts for publication original scientific work, reviews and communication articles written only in English. • Original …Length not stated
- review articleThe Brazilian Journal of Pharmacognosy accepts for publication original scientific work, reviews and communication articles written only in English. • Original …Length not stated
- short communicationThe Brazilian Journal of Pharmacognosy accepts for publication original scientific work, reviews and communication articles written only in English. • Original …Length not stated
- surveyThe Brazilian Journal of Pharmacognosy accepts for publication original scientific work, reviews and communication articles written only in English. • Original …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability
Data and materials, including software/custom code, must support published claims and comply with field standards. Model summary
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations.
Source ↗Publisher website ·- Publication ethics
Biological material must be documented with site/country of origin, identifier name, and voucher specimen location. Model summary
All plant, microorganism and marine organism materials used in the described research should be supported by an indication of the site (including GPS coordinates, if possible) and country of origin, the name of the person identifying the biological material and the location of the voucher specimen.
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Revista Brasileira de Farmacognosia, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- BRAZIL
- Language
- English, Portuguese
- Frequency
- 6 issues per year
- Founded
- 2015
- ISSN
- 0102-695X
- Electronic ISSN
- 1981-528X
- Society / sponsor
- Sociedade Brasileira de Farmacognosia
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
What CAS zone is Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy?
The latest impact factor listed by LetPub is 1.67; CiteScore 3.3, h-index 89.
How long does peer review take at Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 97–182 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Author–date; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy based?
Of the 32 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Brazil (26), Italy (3) and Germany (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy?
According to LetPub and DOAJ records, Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy is indexed in SCIE and Scopus. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy open access, and what is the APC?
Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy is a fully open-access journal. APC about USD 2,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .